Markets
U.S. close in 2 hrs, 37 mins
BUSINESS NEWS
- Market News
- Earnings
- Recalls
- Recession Watch
- Tech News
- Financial Crisis
- Madoff Scandal
- BloggingStocks
- Luxist
- Money Videos
INVESTING
- Stock Quotes
- Stock Charts
- Stock Ticker
- Currencies
- Portfolio
- Stock Screener
- Broker Center
- Mutual Fund Center
- ETF Center
- Money
- 24/7 Wall St.
- Financial Glossary
PERSONAL FINANCE AT WALLETPOP
- Bargains
- Banking
- Budget
- Calculators
- College Finance
- Community
- Credit
- Deals
- Debt
- Economizer
- Food
- Home
- Fraud
- Insurance
- Interest Rates
- Loans
- Mortgages
- Real Estate
- Recalls
- Recession
- Retirement
- Saving
- Simplification
- Specials
- Taxes
SMALL BUSINESS
Medarex, Inc. Announces Expiration of Offer to Repurchase its 2.25% Convertible Senior Notes due May 15, 2011
Business Wire
Medarex, Inc., a wholly owned subsidiary of
Bristol-Myers
Squibb Company (NYSE: BMY), announced today that its offer to
repurchase its 2.25% Convertible Senior Notes due May 15, 2011 (the
“Convertible Notes”) expired on October 23, 2009 pursuant to terms of
the notice of change in control to holders of the Convertible Notes
dated September 23, 2009.
The trustee for the Convertible Notes has advised Medarex that no
Convertible Notes were tendered in the offer to repurchase.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company committed to
discovering, developing and delivering innovative medicines that help
patients prevail over serious diseases. For more information, please
visit
www.bms.com.
This press release is neither an offer to purchase nor a solicitation of
an offer to sell the Convertible Notes of Medarex.
Copyright Business Wire 2009
2009-10-26 09:00:00
COMMENTS ( 0 )